30 Day Trial

DePuy Synthes Accelerates Commitment to Digital Surgery in 2020
January 24, 2020, 9:45 am
DePuy Synthes reports 4Q19 orthopedic revenue of USD $2,275 million, +0.6% vs. 4Q18, with full year 2019 revenue of $8,839 million, -0.5% vs. 2018.

Medacta Announces First Surgeries and CE Marking for Sports Medicine Products
January 24, 2020, 9:45 am
Medacta gained CE Mark approval for several of its sports medicine devices, and marked multiple first sports medicine procedures in Australia and the U.S.

TDM USA Launches New Value-Based Orthopedic Systems
January 20, 2020, 10:45 am
TDM USA launched 12 systems to treat traumatic injuries of the upper and lower extremities.

Inspired Spine Reaches 1,000 OLLIF Procedure Milestone
January 20, 2020, 10:45 am
Inspired Spine achieved the milestone of completion of 1,000 Oblique Lateral Lumbar Interbody Fusion procedures.

Wright Medical Shareholder Files Suit to Halt Stryker Acquisition
January 17, 2020, 4:00 pm
A Wright Medical shareholder filed a suit against Wright, its board and Stryker, claiming that the Solicitation Statement submitted to shareholders in association with the proposed acquisition is false and misleading.

Rejoint YourKnee Receives CE Mark Approval

January 16, 2020, 12:15 pm
REJOINT received CE Mark approval for the YourKnee™ patient-specific 3D-printed total knee replacement.

CoreLink Hits Milestone of 5,000 Implants with 3D-Printed Technology
January 16, 2020, 12:15 pm
CoreLink has implanted over 5,000 3D-printed spinal devices that employ proprietary Mimetic Metal® additively-manufactured technology. 

Medicrea Announces Partnership Discussions and Proposed Capital Increase
January 14, 2020, 1:30 pm
Medicrea announced a preliminary discussion for acquisition by or partnership with U.S. spine players, as well as a proposed capital funding increase.

RTI Surgical to Become Pure-Play Spine Company with Sale of OEM Business
January 14, 2020, 1:30 pm
RTI Surgical announced a definitive agreement to sell its OEM business to Montagu Private Equity for a total of $490 million.

Embody Gains Additional Funding for ACL Repair
January 14, 2020, 1:30 pm
Embody is receiving a $2.5 million Phase II research award. Funds will support development and clinical assessment of collagen-based MICROBRACE™ ACL technology for anterior cruciate ligament repair.
Page Navigation
Prev
Next
1 2 3 4 5 Next

 


It's important to know that ORTHOFLASH (like many ORTHOWORLD resources) is included with Membership. The full menu of Membership benefits is outlined on this page. Still have questions? Or, would you prefer personal attention?
Fran Bursic welcomes your inquiry by phone at 440.543.2101 or via email.​

Read more from ORTHOWORLD:

 
About ORTHOWORLD | Contact Us | Our Mission | Customer Credo | Privacy Policy | Terms of Service